Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Current Deferred Revenue (2009 - 2026)

Updated

Idexx Laboratories (IDXX) posted Current Deferred Revenue of $36.4 million for Q2 2026, up 0.2% from $36.32 million a year earlier and up 0.2% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Current Deferred Revenue (2009 - 2026) Analysis & Trends

At the end of FY2025, Idexx Laboratories' Current Deferred Revenue came in at $35.26 million, up 4.3% from FY2024.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
  • In prior years, Idexx Laboratories' Current Deferred Revenue was $33.8 million in FY2024 (-9.1%), $37.2 million in FY2023 (-2.0%), $37.94 million in FY2022 (-5.2%) and $40.03 million in FY2021 (-6.0%).
  • The Q2 2026 figure stands as the highest quarterly Current Deferred Revenue since Q3 2024.
  • On a year-over-year basis, Current Deferred Revenue has increased in each of the last three quarters, with an average decline of 2.2% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2025, with growth of 4.3%; the weakest was Q4 2024, with a decline of 9.1%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $36.33 million (Q1 2026), $35.26 million (Q4 2025) and $35.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.40 Mn
Mar 31, 2026 36.33 Mn
Dec 31, 2025 35.26 Mn
Sep 30, 2025 35.69 Mn
Jun 30, 2025 36.32 Mn
Mar 31, 2025 35.00 Mn
Dec 31, 2024 33.80 Mn
Sep 30, 2024 38.43 Mn
Jun 30, 2024 38.00 Mn
Mar 31, 2024 38.19 Mn
Dec 31, 2023 37.20 Mn
Sep 30, 2023 37.28 Mn
Jun 30, 2023 37.78 Mn
Mar 31, 2023 37.84 Mn
Dec 31, 2022 37.94 Mn
Sep 30, 2022 40.81 Mn
Jun 30, 2022 40.78 Mn
Mar 31, 2022 40.91 Mn
Dec 31, 2021 40.03 Mn
Sep 30, 2021 41.13 Mn
API Access

Idexx Laboratories Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY